IL15 and neoplasm: Cytokine signalization components have been modified to boost CAR-NK activity by incorporating the inducible MyD88/CD40 (iMC) system as an independent co-stimulator of an IL-15 secreting CAR-NK to enhance cell persistence and tumor control (95, 96).